Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study

Jin Ge; Mark J. Pletcher; Jennifer C. Lai; for the N3C Consortium

doi:10.1101/2021.06.03.21258312

Article Information

doi

https://doi.org/10.1101/2021.06.03.21258312

History

June 7, 2021.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

Jin Ge, MD, MBA1,*,
Mark J. Pletcher, MD, MPH2,3,
Jennifer C. Lai, MD, MBA1,
for the N3C Consortium

¹Division of Gastroenterology and Hepatology, Department of Medicine, University of California – San Francisco, San Francisco, CA
²Department of Epidemiology and Biostatistics, University of California – San Francisco, San Francisco, CA
³Division of General Internal Medicine, Department of Medicine, University of California – San Francisco, San Francisco, CA

↵*Corresponding Author
: Jin Ge, MD, MBA, 513 Parnassus Avenue, S-357, San Francisco, CA 94143, E-mail: jin.ge{at}ucsf.edu, Fax: 415-476-0659

¹Owl Health Works LLC, Indianapolis, IN
²Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD
³Center for Health AI, University of Colorado Anchutz Medical Campus, Aurora, CO